Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling

被引:22
作者
Chu, GX
Kerr, JP
Mitton, B
Egnaczyk, GF
Vazquez, JA
Shen, ML
Kilby, GW
Stevenson, TI
Maggio, JE
Vockley, J
Rapundalo, ST
Kranias, EG
机构
[1] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA
[2] Pfizer Global Res & Dev, Ann Arbor, MI USA
[3] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA
关键词
phospholamban; phosphorylation; contractility; energetics; heart failure;
D O I
10.1096/fj.04-2025fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Depressed sarcoplasmic reticulum (SR) Ca-cycling is a hallmark of human and experimental heart failure. Strategies to improve this impairment by either increasing SERCA2a levels or decreasing phospholamban (PLN) activity have been suggested as promising therapeutic targets. Indeed, ablation of PLN gene in mice was associated with greatly enhanced cardiac Ca-cycling and performance. Intriguingly, this hyperdynamic cardiac function was maintained throughout the lifetime of the mouse without observable pathological consequences. To determine the cellular alterations in the expression or modification of myocardial proteins, which are associated with the enhanced cardiac contractility, we performed a proteomics-based analysis of PLN knockout (PLN-KO) hearts in comparison to isogenic wild-types. By use of 2-dimensional gel electrophoresis (2-DE), similar to3300 distinct protein spots were detected in either wild-type or PLN-KO ventricles. Protein spots observed to be altered between PLN-KO and wild-type hearts were subjected to tryptic peptide mass fingerprinting for identification by MALDI-TOF mass spectrometry in combination with LC/MS/MS analysis. In addition, two-dimensional P-32-autoradiography was performed to analyze the phosphorylation profiles of PLN-KO cardiomyocytes. We identified alterations in the expression level of more than 100 ventricular proteins, along with changes in phosphorylation status of important regulatory proteins in the PLN-KO. These protein changes were observed mainly in two subcellular compartments: the cardiac contractile apparatus, and metabolism/energetics. Our findings suggest that numerous alterations in protein expression and phosphorylation state occurred upon ablation of PLN and that a complex functional relationship among proteins involved in calcium handling, myofibrils, and energy production may exist to coordinately maintain the hyperdynamic cardiac contractile performance of the PLN-KO mouse in the long term.
引用
收藏
页码:1725 / +
页数:30
相关论文
共 35 条
[21]  
Perry SV, 1998, J MUSCLE RES CELL M, V19, P575
[22]   EXPRESSION OF TRANSDUCED TROPOMYOSIN-1 CDNA SUPPRESSES NEOPLASTIC GROWTH OF CELLS TRANSFORMED BY THE RAS ONCOGENE [J].
PRASAD, GL ;
FULDNER, RA ;
COOPER, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :7039-7043
[23]   Translocation of HSP27 to sarcomere induced by ischemic preconditioning in isolated rat hearts [J].
Sakamoto, K ;
Urushidani, T ;
Nagao, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (01) :137-142
[24]   Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2 [J].
Sanbe, A ;
Fewell, JG ;
Gulick, J ;
Osinska, H ;
Lorenz, J ;
Hall, DG ;
Murray, LA ;
Kimball, TR ;
Witt, SA ;
Robbins, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) :21085-21094
[25]   Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation [J].
Sato, Y ;
Kiriazis, H ;
Yatani, A ;
Schmidt, AG ;
Hahn, H ;
Ferguson, DG ;
Sako, H ;
Mitarai, S ;
Honda, R ;
Mesnard-Rouiller, L ;
Frank, KF ;
Beyermann, B ;
Wu, GY ;
Fujimori, K ;
Dorn, GW ;
Kranias, EG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) :9392-9399
[26]   The enhanced contractility in phospholamban deficient mouse hearts is not associated with alterations in Ca2+-sensitivity or myosin ATPase-activity of the contractile proteins [J].
Schwinger, RHG ;
Brixius, K ;
Savvidou-Zaroti, P ;
Bölck, B ;
Zobel, C ;
Frank, K ;
Kranias, EG ;
Hoischen, S ;
Erdmann, E .
BASIC RESEARCH IN CARDIOLOGY, 2000, 95 (01) :12-18
[27]   Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels [J].
Shevchenko, A ;
Wilm, M ;
Vorm, O ;
Mann, M .
ANALYTICAL CHEMISTRY, 1996, 68 (05) :850-858
[28]   The enhanced contractility of the phospholamban-deficient mouse heart persists with aging [J].
Slack, JP ;
Grupp, IL ;
Dash, R ;
Holder, D ;
Schmidt, A ;
Gerst, MJ ;
Tamura, T ;
Tilgmann, C ;
James, PF ;
Johnson, R ;
Gerdes, AM ;
Kranias, EG .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (05) :1031-1040
[29]   Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy [J].
Song, QJ ;
Schmidt, AG ;
Hahn, HS ;
Carr, AN ;
Frank, B ;
Pater, L ;
Gerst, M ;
Young, K ;
Hoit, BD ;
McConnell, BK ;
Haghighi, K ;
Seidman, CE ;
Seidman, JG ;
Dorn, SW ;
Kranias, EG .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (06) :859-867
[30]   Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection [J].
Stangl, K ;
Günther, C ;
Frank, T ;
Lorenz, M ;
Meiners, S ;
Röpke, T ;
Stelter, L ;
Moobed, M ;
Baumann, G ;
Kloetzel, PM ;
Stangl, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (03) :542-549